Article Details
Retrieved on: 2022-11-02 02:20:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... a potentially best-in-class monoclonal antibody that targets SIRPα. ... "Sairopa was founded to develop a portfolio of therapeutic antibodies ...
Article found on: www.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here